UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications

Cardiovascular research, 2023-01, Vol.118 (17), p.3288-3304

2023

Volltextzugriff (PDF)

PPAR Agonists and Metabolic Syndrome: An Established Role?

International journal of molecular sciences, 2018-04, Vol.19 (4), p.1197

2018

Volltextzugriff (PDF)

Clinical approach to the inflammatory etiology of cardiovascular diseases

Pharmacological research, 2020-09, Vol.159, p.104916-104916, Article 104916

2020

Volltextzugriff (PDF)

Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches

European journal of clinical investigation, 2021-07, Vol.51 (7), p.e13519-n/a

2021

Volltextzugriff (PDF)

Metformin: From diabetes to cancer to prolongation of life

Pharmacological research, 2024-10, Vol.208, p.107367, Article 107367

2024

Volltextzugriff (PDF)

The pharmacology of statins

Pharmacological research, 2014-10, Vol.88, p.3-11

Sirtori, Cesare R.

2014

Volltextzugriff (PDF)

Present therapeutic role of cholesteryl ester transfer protein inhibitors

Pharmacological research, 2018-02, Vol.128, p.29-41

2018

Volltextzugriff (PDF)

Pollution from fine particulate matter and atherosclerosis: A narrative review

Environment international, 2023-05, Vol.175, p.107923-107923, Article 107923

2023

Volltextzugriff (PDF)

Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure

Reviews in endocrine & metabolic disorders, 2021-06, Vol.22 (2), p.257-274

2021

Volltextzugriff (PDF)

Impact of PPAR-Alpha Polymorphisms-The Case of Metabolic Disorders and Atherosclerosis

International journal of molecular sciences, 2019-09, Vol.20 (18), p.4378

2019

Volltextzugriff (PDF)

Recent advances in synthetic pharmacotherapies for dyslipidaemias

European Journal of Preventive Cardiology, 2020-10, Vol.27 (15), p.1576-1596

2020

Volltextzugriff (PDF)

Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation

Nutrients, 2018-09, Vol.10 (9), p.1249

2018

Volltextzugriff (PDF)

Risk identification and possible countermeasures for muscle adverse effects during statin therapy

European journal of internal medicine, 2015-03, Vol.26 (2), p.82-88

2015

Volltextzugriff (PDF)

Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials

Annals of medicine (Helsinki), 2018-10, Vol.50 (7), p.565-575

2018

Volltextzugriff (PDF)

Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study

Nutrition journal, 2019-02, Vol.18 (1), p.13-13, Article 13

2019

Volltextzugriff (PDF)

Impact of Atorvastatin on Skeletal Muscle Mitochondrial Activity, Locomotion and Axonal Excitability-Evidence from ApoE -/- Mice

International journal of molecular sciences, 2022-05, Vol.23 (10), p.5415

2022

Volltextzugriff (PDF)

Influence of body variables in the development of metabolic syndrome-A long term follow-up study

PloS one, 2018-02, Vol.13 (2), p.e0192751-e0192751

2018

Volltextzugriff (PDF)

Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial

European journal of nutrition, 2018-03, Vol.57 (2), p.499-511

2018

Volltextzugriff (PDF)

Proprotein Convertase Subtilisin/Kexin Type 9: A View beyond the Canonical Cholesterol-Lowering Impact

The American journal of pathology, 2021-08, Vol.191 (8), p.1385-1397

2021

Volltextzugriff (PDF)

Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE−/− mice

Scientific reports, 2017-03, Vol.7 (1), p.44503, Article 44503

2017

Volltextzugriff (PDF)

Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: Focus on dietary proteins

Atherosclerosis, 2009-03, Vol.203 (1), p.8-17

2009

Volltextzugriff (PDF)

PCSK9 Confers Inflammatory Properties to Extracellular Vesicles Released by Vascular Smooth Muscle Cells

International journal of molecular sciences, 2022-11, Vol.23 (21), p.13065

2022

Volltextzugriff (PDF)

Impact of Soy β-Conglycinin Peptides on PCSK9 Protein Expression in HepG2 Cells

Nutrients, 2021-12, Vol.14 (1), p.193

2021

Volltextzugriff (PDF)

PCSK9 inhibition and inflammation: A narrative review

Atherosclerosis, 2019-09, Vol.288, p.146-155

2019

Volltextzugriff (PDF)

1 – 25 von 393

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(372)
Mit Volltextzugriff
(344)

Publikationsform

Artikel
(392)
Berichte
(1)

Sprache

Englisch
(393)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications

PPAR Agonists and Metabolic Syndrome: An Established Role?

Clinical approach to the inflammatory etiology of cardiovascular diseases

Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches

Metformin: From diabetes to cancer to prolongation of life

The pharmacology of statins

Present therapeutic role of cholesteryl ester transfer protein inhibitors

Pollution from fine particulate matter and atherosclerosis: A narrative review

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure

Impact of PPAR-Alpha Polymorphisms-The Case of Metabolic Disorders and Atherosclerosis

Recent advances in synthetic pharmacotherapies for dyslipidaemias

Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation

Risk identification and possible countermeasures for muscle adverse effects during statin therapy

Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials

Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study

Impact of Atorvastatin on Skeletal Muscle Mitochondrial Activity, Locomotion and Axonal Excitability-Evidence from ApoE -/- Mice

Influence of body variables in the development of metabolic syndrome-A long term follow-up study

Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial

Proprotein Convertase Subtilisin/Kexin Type 9: A View beyond the Canonical Cholesterol-Lowering Impact

Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE−/− mice

Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: Focus on dietary proteins

PCSK9 Confers Inflammatory Properties to Extracellular Vesicles Released by Vascular Smooth Muscle Cells

Impact of Soy β-Conglycinin Peptides on PCSK9 Protein Expression in HepG2 Cells

PCSK9 inhibition and inflammation: A narrative review

Suchergebnisse filtern